BTIG Maintains Buy on GeneDx Holdings, Lowers Price Target to $90
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $170 to $90.
BTIG analyst Mark Massaro maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and lowers the price target from $170 to $90.